$CALM

Cal-Maine Shares Tumble as Egg Glut Wipes Out Quarterly Profit

Cal-Maine Foods (CALM) reported a fiscal Q1 loss of $1.26 per share, missing estimates, as revenue fell 41.5% due to an egg supply glut. Shares dropped 8% premarket, hitting a 52-week low. The company's conventional egg segment saw a 59.3% price decline, while specialty eggs and prepared foods showed resilience.

Original reporting
Published Sep 30, 2026, 1:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 2:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CALM
Bearish
high confidence
Mentioned
$CALM
Relevance
8/10
AlphAI data visualization · based on finance.biggo.com
Decision brief

The 30-second read

$CALMBearishHigh
01

Why it matters

The earnings miss underscores the severity of the current egg‑price collapse, prompting a sharp sell‑off and raising concerns for peers.

02

Market read

The unexpected loss and revenue decline triggered an 8% pre‑market drop, signaling immediate trading risk for CALM and related agribusiness stocks.

03

What to watch

The company's sizable cash reserves and ongoing share‑buyback program may provide support if investors view the loss as temporary.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Cal-Maine Foods is the largest U.S. egg producer; its earnings are a bellwether for commodity‑sensitive agribusinesses.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine reported a Q1 loss of $1.26 per share and a 41.5% revenue decline, causing the stock to tumble up to 8% pre‑market.

Expected impact

downward pressure as investors price in weaker earnings and no guidance

Evidence & confidence

The surprise loss and sharp revenue drop exceed expectations, and the stock already fell 8% on the news; no mitigating guidance was provided.

Market effects

Egg and broader agricultural commodity producers may face pressure as the supply glut highlights pricing risk.

U.S. agribusiness stocks could see modest weakness in the near term.

Limited to U.S. food‑production sector; no broader macro impact.

Counterpoint

If the supply glut eases faster than expected, the stock could rebound on the back of its strong balance sheet and share‑repurchase capacity.

Key entities

  • Sherman Miller

    President and CEO of Cal-Maine, provided commentary on results and future strategy.

Related articles

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CALMMedAI 8/10

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.

$CALMMedAI 8/10

Cal-Maine Foods Q1 2027 Earnings Call: Complete Transcript - Cal-Maine Foods (NASDAQ:CALM)

Cal-Maine Foods (NASDAQ:CALM) reported Q1 FY2027 net sales down 41.5% to $539.6M and a net loss of $58.6M. The company faces pressure from an oversupplied egg market but is expanding specialty eggs and prepared foods. It plans a 60% increase in prepared foods capacity by H1 FY2028 and has $767.6M in cash. Management repurchased $14.9M in shares post-quarter, focusing on long-term growth.